Insider Trading History of Plunkett Matthew

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Plunkett Matthew since 2014. The trader's CIK number is 1557551. At the time of the last reporting, Plunkett Matthew was the EVP, Corporate Development of Cti Biopharma Corp. (stock ticker symbol CTIC). Also see all insider trading activities at Cti Biopharma Corp.


Yearly summary of insider trading at Cti Biopharma Corp (CTIC) by Plunkett Matthew

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 CTIC 0 $0 30,000 $29,730 0 $0
2015 CTIC 0 $0 342,568 $588,271 0 $0
2014 CTIC 0 $0 384,936 $1,187,130 0 $0


Insider trading of Cti Biopharma Corp (CTIC) by Plunkett Matthew

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-03-04 CTIC Sale 10,000 .59 5,900
2016-02-04 CTIC Sale 10,000 1.16 11,580
2016-01-04 CTIC Sale 10,000 1.23 12,250
2015-12-04 CTIC Sale 10,000 1.00 9,970
2015-11-04 CTIC Sale 10,000 1.39 13,850
2015-10-05 CTIC Sale 10,000 1.52 15,230
2015-09-29 CTIC Sale 75,000 1.42 106,575
2015-09-24 CTIC Sale 75,869 1.56 118,583
2015-09-04 CTIC Sale 10,000 1.54 15,390
2015-08-04 CTIC Sale 10,000 1.84 18,450
2015-07-06 CTIC Sale 10,000 1.95 19,500
2015-06-04 CTIC Sale 10,000 2.06 20,650
2015-05-04 CTIC Sale 10,000 1.86 18,580
2015-04-06 CTIC Sale 16,569 1.89 31,315
2015-03-23 CTIC Sale 59,130 1.97 116,190
2015-03-04 CTIC Sale 12,000 2.42 28,980
2015-02-04 CTIC Sale 12,000 2.23 26,712
2015-01-05 CTIC Sale 12,000 2.36 28,296
2014-12-04 CTIC Sale 12,000 2.23 26,820
2014-11-04 CTIC Sale 12,000 2.39 28,667
2014-10-06 CTIC Sale 12,000 2.40 28,740
2014-09-23 CTIC Sale 51,818 2.54 131,617
2014-09-22 CTIC Sale 51,817 2.56 132,651
2014-09-04 CTIC Sale 27,301 2.48 67,679
2014-08-04 CTIC Sale 12,000 2.49 29,832
2014-07-07 CTIC Sale 12,000 2.88 34,620
2014-06-04 CTIC Sale 12,000 3.02 36,276
2014-05-05 CTIC Sale 12,000 2.95 35,448
2014-03-21 CTIC Sale 170,000 3.73 634,780

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Plunkett Matthew (EVP, Corporate Development of Cti Biopharma Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.